Stock HRTX HERON THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Heron Therapeutics, Inc.

Equities

HRTX

US4277461020

Market Closed - Nasdaq
Other stock markets
 01:30:00 09/05/2024 am IST 		5-day change 1st Jan Change
3.01 USD +4.88% Intraday chart for Heron Therapeutics, Inc. +28.63% +77.06%
07/05 Transcript : Heron Therapeutics, Inc., Q1 2024 Earnings Call, May 07, 2024
07/05 Heron Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Heron Therapeutics: Q1 Earnings Snapshot
AQ
Heron Therapeutics Announces First Quarter 2024 Financial Results and Highlights Recent Corporate Updates
PR
Heron Therapeutics to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024
PR
Heron Therapeutics to Host Investor Day on May 15, 2024 in New York City
PR
Heron Therapeutics Announces Presentation at the 23rd Annual Needham Virtual Healthcare Conference
PR
Heron Therapeutics : Q4 2023 Earnings Call Presentation
PU
Heron Therapeutics : Q4 2023 Earnings Call Presentation
PU
Heron Therapeutics: Q4 Earnings Snapshot
AQ
Heron Therapeutics Announces Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Corporate Updates
PR
Heron Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results On Tuesday, March 12, 2024
PR
Heron Therapeutics Announces FDA Approval of ZYNRELEF Indication Expansion to Include Additional Orthopedic and Soft Tissue Procedures
AQ
Heron Therapeutics Announces FDA Approval of ZYNRELEF® Indication Expansion to Include Additional Orthopedic and Soft Tissue Procedures
PR
Heron Therapeutics Announces Partnership with CrossLink Life Sciences to Expand Promotional Effort for ZYNRELEF, the First and Only Non-Opioid Dual Acting Local Anesthetic for Post-Operative Pain
AQ
Heron Therapeutics Announces Partnership with CrossLink Life Sciences to Expand Promotional Effort for ZYNRELEF®, the First and Only Non-Opioid Dual Acting Local Anesthetic for Post-Operative Pain
PR
Heron Therapeutics: Q3 Earnings Snapshot
AQ
Heron Therapeutics Announces Third Quarter 2023 Financial Results and Updates Financial Guidance
PR
Heron Therapeutics to Report Third Quarter 2023 Financial Results On Tuesday, November 14, 2023
PR
Biotech Stocks: Exciting Breakthroughs and Emerging Trends to Watch - INBS, HUMA, HRTX, HALB, RMED
AQ
Heron Therapeutics : Q2 2022 Earnings Call Presentation
PU
Heron Therapeutics: Q2 Earnings Snapshot
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. HRTX Stock
  4. News Heron Therapeutics, Inc.
  5. Press Releases
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW